​
​

Orgenesis (ORGS) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Orgenesis Revenue Highlights

Latest Revenue (Y)

$530.00K

Latest Revenue (Q)

$347.00K

Orgenesis Revenue by Period

Orgenesis Revenue by Year

DateRevenueChange
2023-12-31$530.00K-98.53%
2022-12-31$36.02M1.47%
2021-12-31$35.50M363.96%
2020-12-31$7.65M-76.99%
2019-12-31$33.26M78.27%
2018-11-30$18.66M84.90%
2017-11-30$10.09M57.71%
2016-11-30$6.40M115.10%
2015-11-30$2.97M100.00%
2014-11-30-100.00%
2013-11-30-100.00%
2012-11-30-100.00%
2011-11-30-100.00%
2010-11-30-100.00%
2009-11-30-100.00%
2008-11-30--

Orgenesis generated $530.00K in revenue during NA 2023, up -98.53% compared to the previous quarter, and up 2.84% compared to the same period a year ago.

Orgenesis Revenue by Quarter

DateRevenueChange
2024-09-30$347.00K41.06%
2024-06-30$246.00K74.47%
2024-03-31$141.00K-101.04%
2023-12-31$-13.60M-12462.73%
2023-09-30$110.00K-98.42%
2023-06-30$6.97M-0.98%
2023-03-31$7.04M-48.30%
2022-12-31$13.62M70.56%
2022-09-30$7.99M10.93%
2022-06-30$7.20M-0.15%
2022-03-31$7.21M4.64%
2021-12-31$6.89M-20.56%
2021-09-30$8.68M-17.72%
2021-06-30$10.54M12.31%
2021-03-31$9.39M308.93%
2020-12-31$2.30M32.79%
2020-09-30$1.73M-1.14%
2020-06-30$1.75M-6.87%
2020-03-31$1.88M-79.31%
2019-12-31$9.08M-0.48%
2019-09-30$9.12M17.58%
2019-06-30$7.76M6.25%
2019-03-31$7.30M25.84%
2018-11-30$5.80M-6.87%
2018-08-31$6.23M56.26%
2018-05-31$3.99M51.25%
2017-12-31$2.64M-21.94%
2017-11-30$3.38M31.81%
2017-08-31$2.56M11.49%
2017-05-31$2.30M24.08%
2017-02-28$1.85M-2.32%
2016-11-30$1.90M2.54%
2016-08-31$1.85M63.34%
2016-05-31$1.13M-25.53%
2016-02-29$1.52M24.86%
2015-11-30$1.22M30.03%
2015-08-31$936.22K14.11%
2015-05-31$820.42K100.00%
2015-02-28-100.00%
2014-11-30-100.00%
2014-08-31-100.00%
2014-05-31-100.00%
2014-02-28-100.00%
2013-11-30-100.00%
2013-08-31-100.00%
2013-05-31-100.00%
2013-02-28-100.00%
2012-11-30-100.00%
2012-08-31-100.00%
2012-05-31-100.00%
2012-02-29-100.00%
2011-11-30-100.00%
2011-08-31-100.00%
2011-05-31-100.00%
2011-02-28-100.00%
2010-11-30-100.00%
2010-08-31-100.00%
2010-05-31-100.00%
2010-02-28-100.00%
2009-11-30-100.00%
2009-08-31-100.00%
2009-05-31-100.00%
2009-02-28--

Orgenesis generated $347.00K in revenue during Q3 2024, up 41.06% compared to the previous quarter, and up 4.97% compared to the same period a year ago.

Orgenesis Revenue Breakdown

Orgenesis Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Eliminations$-4.42M$-5.58M---
Consolidated-$1.28M---
Cell Process Development Services--$2.68M$1.58M-
POC and Hospital Services--$32.82M$6.07M-
Cell manufacturing services----$4.82M
Poc Development Services----$3.11M
Cell process development services----$19.93M
Tech transfer services----$5.40M

Orgenesis's latest annual revenue breakdown by segment (product or service), as of Dec 23: Eliminations (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Mar 23Dec 21Dec 20Dec 19Sep 19Jun 19Mar 19Nov 18
Cell Process Development Services And Hospital Services$347.00K$141.00K----------
Eliminations---$-1.87M--------
Consolidated----$7.04M-------
POC and Hospital Services-----$6.58M$1.78M-----
Cell Process Development Services-----$317.00K$519.00K-----
Cell process development services-------$7.94M$2.75M$4.06M$5.17M-
Cell manufacturing services--------$3.49M$1.03M$296.00K-
Tech transfer services--------$1.86M$1.70M$1.83M-
Poc Services--------$1.01M$962.00K--
Revenue from grants-----------$440.00K

Orgenesis's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Cell Process Development Services And Hospital Services (100.00%).

Orgenesis Revenue Breakdown by Country

Quarterly Revenue by Country

CountrySep 24Mar 24Jun 23
UNITED STATES$265.00K$75.00K$2.57M

Orgenesis's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (100.00%).

Orgenesis Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TNGXTango Therapeutics$36.53M$11.61M
ADAGAdagene$18.11M$833.34K
TFFPTFF Pharmaceuticals$733.87K$650.22K
ORGSOrgenesis$530.00K$347.00K
NRBONeuroBo Pharmaceuticals$7.00K-
DSGNDesign Therapeutics--
RZLTRezolute--
ANTXAN2 Therapeutics--
LIXTLixte Biotechnology--
AVTEAerovate Therapeutics--
TALSTourmaline Bio--
ELYMEliem Therapeutics--
ACRVAcrivon Therapeutics--
ACHLAchilles Therapeutics--
INDPIndaptus Therapeutics--
ONCROncorus--
QNRXQuoin Pharmaceuticals--
KTTAPasithea Therapeutics--

ORGS Revenue FAQ

What is Orgenesis’s yearly revenue?

Orgenesis's yearly revenue for 2023 was $530K, representing a decrease of -98.53% compared to 2022. The company's yearly revenue for 2022 was $36.02M, representing an increase of 1.47% compared to 2021. ORGS's yearly revenue for 2021 was $35.5M, representing an increase of 363.96% compared to 2020.

What is Orgenesis’s quarterly revenue?

Orgenesis's quarterly revenue for Q3 2024 was $347K, a 41.06% increase from the previous quarter (Q2 2024), and a 215.45% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $246K, a 74.47% increase from the previous quarter (Q1 2024), and a -96.47% decrease year-over-year (Q2 2023). ORGS's quarterly revenue for Q1 2024 was $141K, a -101.04% decrease from the previous quarter (Q4 2023), and a -98.00% decrease year-over-year (Q1 2023).

What is Orgenesis’s revenue growth rate?

Orgenesis's revenue growth rate for the last 3 years (2021-2023) was -98.51%, and for the last 5 years (2019-2023) was -98.41%.

What are Orgenesis’s revenue streams?

Orgenesis's revenue streams in c 23 are Eliminations